Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Thompson

Showing results (601-610 of 637) with videos related to

Pageof 64
Sort By:
Psychotherapy and Psychosomatics|September 14, 2017
Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for PsychosisJessica A Hartmann, Patrick D McGorry, Stefanie J Schmidt, et al.
Health Technology Assessment (Winchester, England)|May 31, 2022
Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCTAndrew I Gumley, Simon Bradstreet, John Ainsworth, et al.
Schizophrenia Research|July 15, 2019
Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy peopleAyedh Alqarni, Todd W Mitchell, Patrick D McGorry, et al.
Schizophrenia Research|March 16, 2020
Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trialSumudu Rasangi Mallawaarachchi, G Paul Amminger, John Farhall, et al.
Schizophrenia Research|October 14, 2019
Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosisAyedh Alqarni, Todd W Mitchell, Patrick D McGorry, et al.
Elife|September 27, 2021
Characterization and prediction of clinical pathways of vulnerability to psychosis through graph signal processingCorrado Sandini, Daniela Zöller, Maude Schneider, et al.
JCI Insight|November 3, 2018
Dietary protein restriction reduces circulating VLDL triglyceride levels via CREBH-APOA5-dependent and -independent mechanismsJ Humberto Treviño-Villarreal, Justin S Reynolds, Alexander Bartelt, et al.
The American Journal of Gastroenterology|September 2, 2020
Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk DrinkersJohn B Whitfield, Steven Masson, Suthat Liangpunsakul, et al.
Schizophrenia Bulletin Open|August 15, 2024
Twelve-Month Cognitive Trajectories in Individuals at Ultra-High Risk for Psychosis: A Latent Class AnalysisKelly Allott, Stefanie J Schmidt, Hok Pan Yuen, et al.
Early Intervention in Psychiatry|May 25, 2024
Validating cognitive screening in young people with first-episode psychosis: The CogScreen protocolAlexandra Stainton, Shayden Bryce, Audrey Rattray, et al.
Pageof 64

Showing results (601-610 of 637) with videos related to

Sort By:
Pageof 64
Psychotherapy and Psychosomatics|September 14, 2017
Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for PsychosisJessica A Hartmann, Patrick D McGorry, Stefanie J Schmidt, et al.
Health Technology Assessment (Winchester, England)|May 31, 2022
Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCTAndrew I Gumley, Simon Bradstreet, John Ainsworth, et al.
Schizophrenia Research|July 15, 2019
Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy peopleAyedh Alqarni, Todd W Mitchell, Patrick D McGorry, et al.
Schizophrenia Research|March 16, 2020
Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trialSumudu Rasangi Mallawaarachchi, G Paul Amminger, John Farhall, et al.
Schizophrenia Research|October 14, 2019
Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosisAyedh Alqarni, Todd W Mitchell, Patrick D McGorry, et al.
Elife|September 27, 2021
Characterization and prediction of clinical pathways of vulnerability to psychosis through graph signal processingCorrado Sandini, Daniela Zöller, Maude Schneider, et al.
JCI Insight|November 3, 2018
Dietary protein restriction reduces circulating VLDL triglyceride levels via CREBH-APOA5-dependent and -independent mechanismsJ Humberto Treviño-Villarreal, Justin S Reynolds, Alexander Bartelt, et al.
The American Journal of Gastroenterology|September 2, 2020
Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk DrinkersJohn B Whitfield, Steven Masson, Suthat Liangpunsakul, et al.
Schizophrenia Bulletin Open|August 15, 2024
Twelve-Month Cognitive Trajectories in Individuals at Ultra-High Risk for Psychosis: A Latent Class AnalysisKelly Allott, Stefanie J Schmidt, Hok Pan Yuen, et al.
Early Intervention in Psychiatry|May 25, 2024
Validating cognitive screening in young people with first-episode psychosis: The CogScreen protocolAlexandra Stainton, Shayden Bryce, Audrey Rattray, et al.
Pageof 64